Innate host response in primary human hepatocytes with hepatitis C virus infection

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Yang, Darong ^a   Liu, Nianli ^a   Zuo, Chaohui ^a   Lei, Shoahua ^a   Wu, Xinjiao ^a   Zhou, Fei ^a   Liu, Chen ^b   Zhu, Haizhen ^a  

^a HUNAN UNIVERSITY   (China)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; NONSTRUCTURAL PROTEIN 5A; PROTEIN NS34A; RETINOIC ACID INDUCIBLE PROTEIN I; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; TNFSF10 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL DISRUPTION; CELL ISOLATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE INDUCTION; GENE SILENCING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; INNATE IMMUNITY; LIVER CELL; MOLECULAR MECHANICS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA REPLICATION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS REPLICATION; CELL CULTURE; GENETICS; IMMUNOLOGY; PHYSIOLOGY; TRANSCRIPTION INITIATION; VIROLOGY;

HEPATITIS C VIRUS;

APOPTOSIS; CELLS, CULTURED; DEAD-BOX RNA HELICASES; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; IMMUNITY, INNATE; INTERFERON-BETA; RNA, VIRAL; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTIONAL ACTIVATION; VIRAL PROTEINS;

EID: 80555154422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027552     Document Type: Article

References (38)

1. McHutchison JG, (2004) Understanding hepatitis C. Am J Manag Care 10 (2 Suppl): S21-S29.
2. Laucer GM, Walker BD, (2001) Hepatitis C virus infection. N Engl J Med 345: 41-52.
3. Zhu H, Zhao H, Collins CD, Eckerrode SE, Ruan Q, et al. (2003) Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 37: 1180-1188.
4. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, et al. (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191: 1499-1512.
5. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, et al. (2000) Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6: 578-582.
6. Shoukry NH, Cawthon AG, Walker CM, (2004) Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol 58: 391-424.
7. Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, et al. (2002) Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA 99: 15661-15668.
8. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 623-626.
9. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.
10. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, et al. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102: 9294-9299.
11. Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, et al. (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79: 2689-2699.
12. Wang N, Liang Y, Devaraj S, Wang J, Lemon SM, et al. (2009) Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. J Virol 83: 9824-9834.
13. Zhu H, Elyar J, Foss R, Hemming A, Hall E, et al. (2009) Primary human hepatocyte culture for HCV study. Methods Mol Biol 501: 373-382.
14. Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, et al. (2007) Hepatitis C virus triggers cell death through innate intracellular antiviral defense system. Gastroenterology 133: 1649-1659.
15. Nallagatla SR, Hwang J, Toroney R, Zheng X, Cameron CE, et al. (2007) 5′-triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 318: 1455-1458.
16. Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, et al. (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79: 2689-2699.
17. Balfe P, Mckeating JA, (2009) The complexities of hepatitis C virus entry. J Hepatol 51: 609-611.
18. Clarke P, Tyler KL, (2003) Reovirus-induced apoptosis: a minireview. Apoptosis 8: 141-150.
19. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730-737.
20. Takeuchi O, Akira S, (2008) MDA5/RIG-I and virus recognition. Curr Opin Immunol 20: 17-22.
21. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, et al. (2005) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 102: 2992-2997.
22. Foy E, Li K, Sumpter R Jr, Loo YM, Johnson CL, et al. (2005) Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci USA 102: 2986-2991.
23. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ, (2005) Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein of the mitochondria to evade innate immunity. Proc Natl Acad Sci USA 102: 17717-17722.
24. Podevin P, Carpentier A, Pene V, Aoudjehane L, Carriere M, et al. (2010) Production of infectious hepatitis C virus in primary culture of human adult hepatocytes. Gastroenterology 139: 1355-1364.
25. Banaudha K, Orenstein JM, Korolnek T, St Laurent GC, Wakita T, et al. (2010) Primary hepatocyte culture supports hepatitis C virus replication: a model for infection-associated hepatocarcinogenesis. Hepatology 51: 1922-1932.
26. Stiffler JD, Nguyen M, Sohn JA, Liu C, Kaplan D, et al. (2009) Focal distribution of hepatitis C virus RNA in infected livers. PLoS ONE e6661.
27. Ploss A, Khetani SR, Jones CT, Syder AJ, Trehan K, et al. (2010) Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci USA 107: 3141-3145.
28. Eksioglu EA, Zhu H, Bayouth L, Bess J, Liu H, et al. (2011) Characterization of HCV interaction with Toll-like receptors and RIG-I in liver cells. PLoS ONE e21186.
29. Cheng G, Zhong J, Chisari FV, (2006) Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and-independent mechanisms. Proc Natl Acad Sci USA 103: 8499-8504.
30. Lan L, Gorke S, Rau SJ, Zeisel MB, Hildt E, et al. (2008) Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner. J Immunol 181: 4926-4935.
31. Aly HH, Atsuzawa K, Usuda N, Takada Y, Mizokami M, et al. (2009) Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus. Hepatology 50: 689-696.
32. Kirshner JR, Karpova AY, Kops M, (2005) Identification of TRAIL as an interferon regulatory factor 3 transcriptional target. J Virol 79: 9320-9324.
33. Berg CP, Schlosser SF, Neukirchen DK, Papadakis C, Stein GM, (2009) Hepatitis C virus core protein induces apoptosis-like caspase independent cell death. Virol J 6: 213.
34. Meylan E, Currian J, Hofmann K, Moradpour D, Binder M, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
35. Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, et al. (2006) Viral and therapeutic control of IFN-beta promoter stimulator during hepatitis C virus infection. Proc Natl Acad Sci USA 103: 6001-6006.
36. Lin R, Lacoste J, Nakhaei P, Sun Q, Yang L, et al. (2006) Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 80: 6072-6083.
37. Baril M, Racine ME, Penin F, Lamarre D, (2009) MAVS dimmer is a crucial signaling component of innate immunity and the target of HCV NS3/4A protease. J Virol 83: 1299-1311.
38. Jouan L, Melancon P, Rodrigue-Gervais I, Raymond V, Selliah S, et al. (2010) Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease. J Hepatol 52: 167-175.